Manufacturer:

CSL Behring

Name:

HIZENTRA

Category:

J Code

HCPCS:

J1559

NDC(s):

44206-0451-01, 44206-0452-02, 44206-0454-04, 44206-0455-10, 44206-0456-21, 44206-0457-22, 44206-0458-24,

Primary Type:

Immunoglobulin

Route of Administration:

Subcutaneous

About:

HIZENTRA is a Immunoglobulin drug manufactured by CSL Behring and administered via the Subcutaneous route of administration. The J Code: J1559 is aligned to the drug HIZENTRA.

Hizentra is used to aid the body's immune system in defense against infection using antibodies from healthy human blood plasma. This drug is administered via subcutaneous infusion as opposed to intravenous infusion. This means that patients are able to self-administer Hizentra by infusing under the skin. Patient support for this drug is provided by CSL Behring here: https://www.hizentra.com/hcp/hizentra-connect-support.